A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration.
- DOI
- 10.3390/ijms23137221
- Published
- 2022 Jun 29
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms23137221,
title = {A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration.},
author = {Das S and Dewit N and Jacobs D and Pijnenburg YAL and In 't Veld SGJG and Coppens S and Quaglia M and Hirtz C and Teunissen CE and Vanmechelen E},
year = {2022},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms23137221},
url = {https://doi.org/10.3390/ijms23137221}
}RIS
TY - JOUR TI - A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration. AU - Das S AU - Dewit N AU - Jacobs D AU - Pijnenburg YAL AU - In 't Veld SGJG AU - Coppens S AU - Quaglia M AU - Hirtz C AU - Teunissen CE AU - Vanmechelen E PY - 2022 JO - International journal of molecular sciences DO - 10.3390/ijms23137221 UR - https://doi.org/10.3390/ijms23137221 ER -
APA
S, D., N, D., D, J., YAL, P., SGJG, I. '. V., S, C., M, Q., C, H., CE, T., & E, V. (2022). A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer's Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration.. International journal of molecular sciences. https://doi.org/10.3390/ijms23137221
Source records
- pubmed · retrieved 2026-11-10T07:37:14.109Z